XML 74 R55.htm IDEA: XBRL DOCUMENT v3.25.2
Income Tax Expense - Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable (Details) - USD ($)
12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2023
Australian tax expense [Member]      
Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable [Line Items]      
Loss from continuing operations before income tax expense $ (32,188,619) $ (42,740,210) $ (34,199,019)
Tax at the (8,047,155) (10,685,053) (8,549,755)
Research and Development tax incentive (2,342,136) (323,145) (1,479,371)
Accounting expenditure subject to R&D tax incentive 5,384,221 742,862 3,400,853
Accrued expenses 242,082 44,172 157,681
Amortization (629,735)
Employee leave obligations 917 3,639 3,466
Patent costs 51,254 51,041 51,427
Share-based payments 473,837 660,045 759,472
Unrealized currency movements 43,430 (27,266) 86,276
Subtotal 3,223,870 1,151,348 2,979,804
Tax losses and other timing differences for which no deferred tax asset is recognized 4,827,533 9,533,705 5,569,951
Income tax expense
US tax expense [Member]      
Schedule of Numerical Reconciliation of Income Tax Expense to Prima Facie Tax Payable [Line Items]      
Loss from continuing operations before income tax expense (5,930,262) (5,112,545) (374,170)
Tax at the (1,630,822) (1,405,950) (102,897)
Accrued expenses 28,021 (17,719) 52,578
Amortization (19,075)
Employee leave obligations (13,835) 26,576 48,373
Unrealized currency (gains)/losses (9,784)
Subtotal (14,673) 8,857 100,951
Tax losses and other timing differences for which no deferred tax asset is recognized 1,748,787 1,493,457 39,951
Income tax expense $ 103,292 $ 96,364 $ 38,005